Research Article
Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease
Table 1
The patient characteristics.
| | | Viral hepatitis (HBV + HCV) | ALD | Biliary tract disease | NAFLD | Other liver diseases | Total | | | () | () | () | () | () | () |
| | Sex (male) | 40 (59.7%) | 20 (95.2%) | 14 (70.0%) | 6 (46.2%) | 9 (31.0%) | 89 (59.3%) | | Age (Yr) | 59.9 ± 16.3 | 61.0 ± 12.7 | 66.5 ± 11.6 | 62.5 ± 16.5 | 58.0 ± 15.2 | 60.8 ± 15.1 | | BMI (Kg/m2) | 23.4 ± 4.0 | 23.5 ± 4.3 | 23.6 ± 3.3 | 25.5 ± 2.8 | 22.2 ± 2.7 | 23.4 ± 3.7 | Alcohol consumption
(>20 g/day) | 8 (11.9%) | 17 (81.0%) | 4 (20.0%) | 0 (0.0%) | 5 (17.2%) | 34 (22.7%) |
| Type of liver disease
(% in each etiology) | | | | | | | | Acute hepatitis/liver damage | 6 (9.0%) | 1 (4.7%) | 11 (55.0%) | 0 (0.0%) | 11 (37.9%) | 29 (19.3%) | | Chronic hepatitis/liver damage | 32 (47.7%) | 9 (42.9%) | 4 (20.0%) | 9 (69.2%) | 14 (48.3%) | 68 (45.3%) | | Liver cirrhosis | 11 (16.4%) | 5 (23.8%) | 0 (0.0%) | 1 (7.7%) | 2 (6.9%) | 19 (12.7%) | | With HCC | 18 (26.9%) | 6 (28.6%) | 5 (25.0%) | 3 (23.1%) | 2 (6.9%) | 34 (22.7%) |
| Complications
(% in each etiology) | | | | | | | | Obstructive jaundice | 1 (1.5%) | 0 (0.0%) | 6 (30.0%) | 0 (0.0%) | 0 (0.0%) | 7 (4.7%) | | Biliary tract stone | 8 (11.9%) | 6 (28.6%) | 13 (65.0%) | 1 (7.7%) | 3 (10.3%) | 31 (20.7%) | | Dyslipidemia | 7 (10.4%) | 5 (23.8%) | 8 (40.0%) | 9 (69.2%) | 4 (13.8%) | 33 (22.0%) | | DM | 8 (11.9%) | 9 (42.9%) | 5 (25.0%) | 7 (53.8%) | 3 (10.3%) | 31 (20.7%) |
| | UDCA therapy | 40 (59.7%) | 9 (42.9%) | 5 (25.0%) | 3 (23.1%) | 11 (38.0%) | 68 (45.3%) |
|
|
The values are the means ± standard deviation or numbers (%).
|
